Merck & Co Inc (NYSE:MRK)
| 76.41 BATS BZX Real-Time Price As of 9:55am ET |  -0.02 / -0.03%Today’s Change | 71.72 Today|||52-Week Range 87.80 | -6.59% Year-to-Date |
Latest MRK News | Press Releases
Today’s Trading
| Previous close | 76.43 |
| Today’s open | 76.44 |
| Day’s range | 76.02 - 76.44 |
| Volume | 557,632 |
| Average volume (3 months) | 11,100,107 |
| Market cap | $193.2B |
Data as of 9:55am ET, 04/14/2021
Growth & Valuation
| Earnings growth (last year) | -27.21% |
| Earnings growth (this year) | +9.46% |
| Earnings growth (next 5 years) | +8.00% |
| Revenue growth (last year) | +3.06% |
| P/E ratio | 27.4 |
| Price/Sales | 4.33 |
| Price/Book | 7.63 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| NVSNovartis | -0.04 | -0.05% |
| ABBVAbbVie | -0.90 | -0.84% |
| PFEPfizer | +0.07 | +0.19% |
| LLYEli Lilly and Co | +0.51 | +0.28% |
Data as of 9:55am ET, 04/14/2021
Financials
| Next reporting date | April 29, 2021 |
| EPS forecast (this quarter) | $1.62 |
| Annual revenue (last year) | $48.0B |
| Annual profit (last year) | $7.1B |
| Net profit margin | 14.72% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Kenilworth, New Jersey |
Forecasts
